Mirum Pharmaceuticals, Inc.

Q4 2024 13F Holders

Symbol
MIRM
CUSIP
604749101
Type
Equity
Class
COM
Num filings
211
Total reported value, excl. options
$2.19 B
Manager Report Date Value ($000) Shares Option Type